Pdt Partners, LLC Incyte Corp Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Pdt Partners, LLC holds 4,734 shares of INCY stock, worth $340,516. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,734

Previous 8,266 42.73%

Holding current value

$340,516

Previous $501,000 37.72%

% of portfolio

0.03%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $202,489 - $242,330	-3,532 Reduced 42.73%	4,734 $312,000
Q2 2024 Aug 15, 2024	SELL	$51.18 - $63.75 $1.74 Million - $2.17 Million	-34,063 Reduced 80.47%	8,266 $501,000
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $2.12 Million - $2.5 Million	37,572 Added 789.83%	42,329 $2.41 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $1.54 Million - $1.9 Million	-29,565 Reduced 86.14%	4,757 $298,000
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $230,386 - $262,928	3,988 Added 13.15%	34,322 $1.98 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $678,617 - $840,728	11,134 Added 57.99%	30,334 $1.89 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $1.06 Million - $1.3 Million	15,100 Added 368.29%	19,200 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $275,438 - $344,851	4,100 New	4,100 $329,000
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $2.24 Million - $2.71 Million	-33,957 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $2.32 Million - $2.72 Million	-36,639 Reduced 51.9%	33,957 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $1.14 Million - $1.39 Million	16,596 Added 30.73%	70,596 $4.86 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $111,818 - $122,542	-1,400 Reduced 2.53%	54,000 $4.54 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $906,310 - $1.2 Million	-11,922 Reduced 17.71%	55,400 $4.5 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $888 - $1,074	11 Added 0.02%	67,322 $5.86 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $417,778 - $538,687	4,911 Added 7.87%	67,311 $6.04 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $3.14 Million - $4.61 Million	42,355 Added 211.3%	62,400 $6.49 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $6.54 Million - $8.9 Million	-103,580 Reduced 83.79%	20,045 $1.47 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $140,602 - $184,261	1,925 Added 1.58%	123,625 $10.8 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $7.74 Million - $10.7 Million	121,700 New	121,700 $10.5 Million

Others Institutions Holding INCY

# of Institutions

649

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account